Related Experiment Videos
Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region
G Alecrim M das1, W Alecrim, V Macêdo
1Instituto de Medicina Tropical do Amazonas, Universidade do Amazonas, Universidade de Brasília, Brasília, DF.
Revista Da Sociedade Brasileira De Medicina Tropical
|February 3, 1999
Abstract:
We report for the first time a patient with malaria due to Plasmodium vivax who showed R2 resistance to chloroquine and R3 resistance to mefloquine in the Brazilian Amazon region based on WHO clinical criteria for diagnosis of malaria resistance. Failure was observed with unsupervised oral chloroquine, chloroquine under rigorous supervision and mefloquine in the same scheme. Finally, the patient was cured with oral artesunate.